Craft

Encision

Stock Price

$0.5

2024-10-29

Market Capitalization

$5.6 M

2024-10-29

Revenue

$6.6 M

FY, 2025

Encision Summary

Company Summary

Overview
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments. It offers Active Electrode Monitoring surgical instruments to enhance electrosurgery and reduce the chance for patient injury in minimally invasive surgery. The company’s product line includes a range of articulating instruments, such as scissors, graspers, and dissectors; fixed-tip electrodes; and suction-irrigation electrodes. It also provides handles that are used for advanced laparoscopic procedures, which incorporate stiffer shafts and ergonomic features; and markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products primarily to hospitals through a network of direct and independent sales representatives. 
Type
Public
Status
Active
Founded
1991
HQ
Boulder, CO, US | view all locations
Website
https://www.encision.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Greg Trudel

    Greg Trudel, President and Chief Executive Officer

  • Robert H. Fries, Contract Chief Financial Officer

    LocationsView all

    1 location detected

    • Boulder, CO HQ

      United States

      6797 Winchester Cir

    Encision Financials

    Summary Financials

    Revenue (Q2, 2026)
    $1.5M
    Gross profit (Q2, 2026)
    $697.3K
    Net income (Q2, 2026)
    ($267.8K)
    Cash (Q2, 2026)
    $71.7K
    EBIT (Q2, 2026)
    ($258.5K)
    Enterprise value
    $6.9M

    Footer menu